TerrAscend (STU:TED) E10: €-0.49 (As of Mar. 2026)


STU:TED TerrAscend Corp STU:TED
38 GF Score
Price €0.58
GF Value €0.85
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is TerrAscend E10?

TerrAscend STU:TED -0.86% 38 E10 is €-0.49 as of Mar. 2026. GuruFocus rates STU:TED with a GF Score™ of 38/100 and a GF Value™ of €0.85 (Possible Value Trap). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

TerrAscend's adjusted earnings per share data for the three months ended in Mar. 2026 was €-0.026. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €-0.49 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-06-27), TerrAscend's current stock price is €0.579. TerrAscend's E10 for the quarter that ended in Mar. 2026 was €-0.49. TerrAscend's Shiller PE Ratio of today is .


TerrAscend  (STU:TED) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


TerrAscend E10 Related Terms


TerrAscend E10 Historical Data

* Premium members only.

The historical data trend for TerrAscend's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TerrAscend E10 Chart

TerrAscend Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -0.47

TerrAscend Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 -0.47 -0.49

STU:TED vs ZTS: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, TerrAscend's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TerrAscend Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, TerrAscend's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where TerrAscend's Shiller PE Ratio falls into.


STU:TED
38GF Score
TerrAscend Corp STU:TED
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

TerrAscend E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, TerrAscend's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.026/132.2623*132.2623
=-0.026

Current CPI (Mar. 2026) = 132.2623.

TerrAscend Quarterly Data

per share eps CPI Adj_EPS
201606 -0.004 102.002 -0.005
201609 -0.004 101.765 -0.005
201612 -0.010 101.449 -0.013
201703 -0.019 102.634 -0.024
201706 -0.082 103.029 -0.105
201709 -0.027 103.345 -0.035
201712 0.009 103.345 0.012
201803 -0.013 105.004 -0.016
201806 -0.033 105.557 -0.041
201809 -0.020 105.636 -0.025
201812 -0.074 105.399 -0.093
201903 -0.093 106.979 -0.115
201906 -0.148 107.690 -0.182
201909 -0.110 107.611 -0.135
201912 -1.095 107.769 -1.344
202003 -0.063 107.927 -0.077
202006 -0.053 108.401 -0.065
202009 -0.076 108.164 -0.093
202012 -0.666 108.559 -0.811
202103 -0.067 110.298 -0.080
202106 -0.141 111.720 -0.167
202109 0.213 112.905 0.250
202112 -0.027 113.774 -0.031
202203 -0.073 117.646 -0.082
202206 0.047 120.806 0.051
202209 -1.242 120.648 -1.362
202212 -0.028 120.964 -0.031
202303 -0.084 122.702 -0.091
202306 -0.046 124.203 -0.049
202309 -0.037 125.230 -0.039
202312 -0.138 125.072 -0.146
202403 -0.055 126.258 -0.058
202406 -0.028 127.522 -0.029
202409 -0.072 127.285 -0.075
202412 -0.105 127.364 -0.109
202503 -0.046 129.181 -0.047
202506 -0.147 129.892 -0.150
202509 -0.068 130.287 -0.069
202512 0.009 130.366 0.009
202603 -0.026 132.262 -0.026

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of €-0.49 mean?
TerrAscend (STU:TED) has a E10 of €-0.49 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on TerrAscend and its competitors.
Is TerrAscend's E10 too high?
TerrAscend's current E10 is €-0.49. Overall, TerrAscend has a GF Score™ of 38/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does TerrAscend's E10 compare to ZTS?
TerrAscend's E10 of €-0.49 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on TerrAscend and its competitors. TerrAscend's current E10 is €-0.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TerrAscend stock overvalued right now?
Based on GuruFocus' analysis, TerrAscend (STU:TED) is currently considered Possible Value Trap. The stock's GF Value™ is €0.85, compared to a current price of €0.58 — trading 31.9% below its estimated fair value. The current E10 is €-0.49. TerrAscend's overall GF Score™ is 38/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For TerrAscend (STU:TED), the current E10 is €-0.49 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is TerrAscend (STU:TED) Overvalued in 2026?

Based on GuruFocus' analysis, TerrAscend stock appears to be undervalued. The current stock price of €0.58 is trading 31.9% below its estimated GF Value™ of €0.85. GuruFocus considers TerrAscend to be Possible Value Trap.

Key valuation signals for STU:TED:

  • E10: €-0.49
  • GF Value™: €0.85 vs. price of €0.58 (31.9% below fair value)
  • GF Score™: 38/100 with 5 warning signs

No single metric tells the full story. See the STU:TED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


TerrAscend Business Description

Other Exchanges TSNDF:USATSND:Canada
Address 77 City Centre Drive, Suite 501, East Tower, Mississauga, ON, CAN, L5B 1M5
TerrAscend Corp is a company focused on creating and delivering cannabis products and services that meet the evolving needs of its patients. It also provides education and support programs to physicians and patients through healthcare professionals. In addition, the firm operates in California, Maryland, New Jersey, and Pennsylvania, with retail operations in Ohio and Canada. It operates The Apothecarium and other dispensary retail locations as well as scaled cultivation, processing, and manufacturing facilities in its core markets. The firm has one operating segment, being the cultivation, production, and sale of cannabis products, with subsidiaries located in Canada and the United States. The company generates key revenue from the United States.
38GF Score

Get the complete analysis for STU:TED

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.58
Price
€0.85
GF Value